• Internal search
  • Eddy Pasquier
    +33 (0)


    After completing my PhD in Oncology at the Aix-Marseille University in 2006, I joined the Tumour Biology and Targeting Program led by Maria Kavallaris at the Children's Cancer Institute (Sydney, Australia), where I spent 7.5 years as post-doctoral researcher and junior group leader. In 2014, I was awarded a Marie Sklodowska-Curie Fellowship from the European Research Council, which allowed me to come back to France and become a member of the Center for Research in Oncobiology and Oncopharmacology (INSERM U911 – Marseille). Finally, I joined the iSCB group in October 2016 when I was recruited by the CNRS as a permanent researcher (CR1).

    My project aims at identifying and validating novel therapeutic targets in refractory cancers by combining high-throughput screening and chemogenomic technologies. My research focuses on pharmacology (i.e. anti-cancer agents and drug repurposing) and functional genomics. I'm particularly interested in hard-to- treat cancers such as neuroblastoma, glioblastoma, angiosarcoma and acute leukaemias.